uce
ProgressImage ProgressImage
Brooks Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 533543 border-img ISIN Demat INE650L01011 border-img Book Value 26.17 border-img NSE Symbol BROOKS border-img Div & Yield % 0 border-img Market Cap ( Cr.) 274.59 border-img P/E 0 border-img EPS 0.19 border-img Face Value 10
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales21.7524.3215.70
Other Operating Income0.000.000.00
Other Income 0.160.090.05
Total Income21.9024.4115.76
Total Expenditure 20.6522.6015.68
PBIDT1.251.810.08
Interest 0.210.190.17
PBDT1.041.62-0.09
Depreciation0.430.440.44
Tax0.030.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax0.581.18-0.53
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item0.581.18-0.53
    
EPS (Unit Curr.)0.230.46-0.22
EPS (Adj) (Unit Curr.)0.230.46-0.22
Calculated EPS (Unit Curr.)0.220.45-0.22
Calculated EPS (Adj) (Unit Curr.)0.220.45-0.22
Calculated EPS (Ann.) (Unit Curr.)0.881.80-0.86
Calculated EPS (Adj) (Ann.) (Unit Curr.)0.881.80-0.85
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity26.2526.2524.70
Reserve & Surplus32.0832.0832.08
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)5.757.440.51
PBDTM(%)4.786.66-0.57
PATM(%)2.674.85-3.38
x
x
×
Let's Chat
close
refresh